Content area

|
|

Lavmolekylært heparin som profylakse mod venøs tromboemboli hos indlagte medicinske patienter

Forfatter(e)
Jonas Emil Sabroe & Søren Martin Madsen Medicinsk Afdeling, Sjællands Universitetshospital, Køge Ugeskr Læger 2016;178:V04160240
Blad nummer: 
Sidetal: 
2-5
Low molecular weight heparin as venous thromboembolism prophylaxis in hospitalized medical patients
Ugeskr Læger 2016;178:V04160240In this study we reviewed the literature for meta-analyses investigating the effect and risk associated with low molecular weight heparin (LMWH) as venous thromboembolism (VTE) prophylaxis in hospitalized medical patients. Furthermore, we identified reputable clinical practice guidelines for VTE prophylaxis in hospitalized medical patients. We included six meta-analyses and two guidelines. Meta-analyses showed varying results of LMWH as VTE prophylaxis. Both guidelines recommend pharmacological VTE prophylaxis for selected hospitalized medical patients.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Pedram Kazemi-Esfarjani | 28/11
2 kommentarer
af David McWhan | 27/11
4 kommentarer
af Ulf Bern Jensen | 24/11
2 kommentarer
af Bodil Marie Nielsen | 24/11
2 kommentarer
af Jan Nielsen | 23/11
1 Kommentar
af Toke Seierøe Barfod | 23/11
2 kommentarer
af Thorkild I.A. Sørensen | 20/11
1 Kommentar
af Kim Varming | 20/11
1 Kommentar
af Niels Holmark Andersen | 20/11
1 Kommentar